Study finds remdesivir-resistant version of COVID-19 in renal transplant recipients

Recent studies have shown that patients with weakened immune systems—which enables the virus that causes COVID-19 to remain longer in the body, copy itself, and continually change—may enable the development of new, slightly different versions of the virus (variants).

Related Keywords

Johni Hogan ,Adriana Heguy ,Emily Henderson ,Langone Health ,Grossman School Of Medicine ,Langone Genome Technology Center ,Department Of Pathology ,Long Island School Of Medicine ,Department Of Medicine ,Genome Technology Center ,Island School ,Lead Author ,Assistant Professor ,Clinical Infectious Diseases ,Genomics Industry Focus ,Covid 19 ,Remdesivir ,Transplant ,Coronavirus ,Drugs ,Enetic ,Enome ,Shiv ,Immune System ,Kidney ,Medicine ,Utation ,Pandemic ,Olymerase ,Protein ,Itonavir ,Spike Protein ,Virus ,